Literature DB >> 34038423

SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans.

Tomokazu Konishi1.   

Abstract

SARS-CoV-2 infection in minks has become a serious problem, as the virus may mutate and reinfect humans; some countries have decided to cull minks. Here, the virus sequencing data in minks were analysed and compared to those of human-virus. Although the mink-virus maintained the characteristics of human-virus, some variants rapidly mutated, adapting to minks. Some mink-derived variants infected humans, which accounted for 40% of the total SARS-CoV-2 cases in the Netherlands. These variants appear to be less lethal and infective compared to those in humans. Variants that have mutated further among minks were not found in humans. Such mink-viruses might be suitable for vaccination for humans, such as in the case of the smallpox virus, which is less infective and toxic to humans.

Entities:  

Year:  2021        PMID: 34038423     DOI: 10.1371/journal.pone.0247626

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  5 in total

1.  Mutations in SARS-CoV-2 are on the increase against the acquired immunity.

Authors:  Tomokazu Konishi
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

Review 2.  Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.

Authors:  Daniele Focosi; Fabrizio Maggi
Journal:  Rev Med Virol       Date:  2021-03-16       Impact factor: 11.043

3.  Role of spike compensatory mutations in the interspecies transmission of SARS-CoV-2.

Authors:  Roger Frutos; Nouara Yahi; Laurent Gavotte; Jacques Fantini; Christian A Devaux
Journal:  One Health       Date:  2022-08-29

4.  SARS-CoV-2 infection in farmed fur animals.

Authors:  Junhua Deng; Ningning Huo; Yalei Chen; Hongchao Wu; Jingjing Bai; Xiangdong Li; Yuxiu Liu; Kegong Tian
Journal:  Transbound Emerg Dis       Date:  2021-07-16       Impact factor: 4.521

5.  Experimental veterinary SARS-CoV-2 vaccine cross neutralization of the Delta (B.1.617.2) variant virus in cats.

Authors:  Ashley Hoyte; Mark Webster; Keith Ameiss; Douglas A Conlee; Nicole Hainer; Kendra Hutchinson; Yulia Burakova; Paul J Dominowski; Eric T Baima; Vickie L King; Everett L Rosey; John M Hardham; Jason Millership; Mahesh Kumar
Journal:  Vet Microbiol       Date:  2022-03-11       Impact factor: 3.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.